First Trust Amex Biotech Index Fund (FBT) Stock Price, Quote, News & History

SPY770.57+0.20%QQQ721.40+0.53%BTC/USD83,495.00+0.67%DIA524.63+0.05%GLD378.50+0.23%TLT80.04−0.11%

Premium

First Trust Amex Biotech Index Fund (FBT) Stock Price, Quote, News & History

FBTARCA

Trade with Public

$271.77

6.292.37%

OverviewNews Holdings Dividends Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Sector

Healthcare

Region

AUM

2.92B

Fund Score

Key Statistics

Open

High

52 Wk High

$275.23

AUM

2.92B

Dividend

$4.69

Ex-Div Date

Dec 13, 2024

Volume

Market Cap

Mgmt Fee

0.4%

P/E Ratio

Prev. Close

$265.48

Low

52 Wk Low

$186.20

Shares Out

7.55M

Yield

2.24%

Div. Freq

Avg. Volume Daily

78.36K

Beta

0.65

Avg. Expense Ratio

0.55%

P/B Ratio

Recent First Trust NYSE Arca Biotechnology Index Fund News

Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets

Cathie Wood’s ARKG bought Ionis, Beam, Veracyte and Scribe Therapeutics. Here are the biotech ETFs that also hold her latest bets.

Chandrima Sanyal

Why Is Natera Stock Gaining Tuesday?

Natera (NTRA) stock rallies following a key NCCN guideline update for Signatera. Also, check out the full NTRA stock analysis.

Vandana Singh

Moderna's Legal Hit Steals Spotlight From Strong Sales

MRNA revenue hits $389M, beating Wall Street estimates. Despite a Q1 loss, Moderna eyes 10% growth and new flu vaccine approvals in 2026.

Vandana Singh

FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars

Moderna's mRNA-1010 flu vaccine clears FDA review, with stock rising ahead of major approvals.

Vandana Singh

Moderna, Mexico Partner To Boost Local Vaccine Production

Moderna signs a long-term deal with Mexico to build local mRNA production, transfer technology, and supply up to 10 million COVID vaccine doses for the 2025–2026 campaign.

Vandana Singh

FAQ

How do I buy First Trust Amex Biotech Index Fund (FBT) stock?

You can purchase shares of First Trust Amex Biotech Index Fund (ARCA:FBT) through any online brokerage.

View our list of the best stock brokerages

Who are First Trust Amex Biotech Index Fund (FBT) competitors?

There are no as such competitors for First Trust Amex Biotech Index Fund.

What is the forecast, or price target, for First Trust Amex Biotech Index Fund (FBT) stock?

There is no analysis for First Trust Amex Biotech Index Fund to provide a consensus price target.

What is the current price for First Trust Amex Biotech Index Fund (FBT)?

The stock price for First Trust Amex Biotech Index Fund (ARCA: FBT) is $ last updated .

Does First Trust Amex Biotech Index Fund (FBT) pay a dividend?

There are no upcoming dividends for First Trust Amex Biotech Index Fund.

When is First Trust Amex Biotech Index Fund (ARCA:FBT) reporting earnings?

First Trust Amex Biotech Index Fund does not have any upcoming earnings scheduled.

Is First Trust Amex Biotech Index Fund (FBT) going to split?

There is no upcoming split for First Trust Amex Biotech Index Fund.

Key Statistics

Open

High

52 Wk High

$275.23

AUM

2.92B

Dividend

$4.69

Ex-Div Date

Dec 13, 2024

Volume

Market Cap

Mgmt Fee

0.4%

P/E Ratio

Prev. Close

$265.48

Low

52 Wk Low

$186.20

Shares Out

7.55M

Yield

2.24%

Div. Freq

Avg. Volume Daily

78.36K

Beta

0.65

Avg. Expense Ratio

0.55%

P/B Ratio

About First Trust Amex Biotech Index Fund

Sector

N/A

Industry

N/A

ETF Details

Sector	Healthcare
Category	High Performer-Mid Growth
Investment Style	Mid Cap Growth
Fund Inception	Jun 19, 2006
Managers	Stan Ueland David G. McGarel Daniel J. Lindquist Roger F. Testin Erik Russo Chris A. Peterson Jon C. Erickson
Definition	This equity fund portfolio contains majority of stocks with strong financial performance and average growth potential

Investment Policy

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.

Top ETF Holdings

Symbol	Name	Share %
CORT	Corcept Therapeutics I...	3.99%
NEO	Neogenomics Inc	3.78%
RGEN	Repligen Corp	3.90%
SM	BeOne Medicines Ltd. S...	3.71%
HALO	Halozyme Therapeutics ...	4.84%
NTRA	Natera Inc	4.62%
GMAB	Genmab A/S (Adr)	4.02%
GILD	Gilead Sciences Inc	3.73%
ILMN	Illumina, Inc.	4.51%
AMGN	Amgen Inc.	3.70%

Key Statistics

Open

High

52 Wk High

$275.23

AUM

2.92B

Dividend

$4.69

Ex-Div Date

Dec 13, 2024

Volume

Market Cap

Mgmt Fee

0.4%

P/E Ratio

Prev. Close

$265.48

Low

52 Wk Low

$186.20

Shares Out

7.55M

Yield

2.24%

Div. Freq

Avg. Volume Daily

78.36K

Beta

0.65

Avg. Expense Ratio

0.55%

P/B Ratio

Recent First Trust NYSE Arca Biotechnology Index Fund News

FAQ

How do I buy First Trust Amex Biotech Index Fund (FBT) stock?

You can purchase shares of First Trust Amex Biotech Index Fund (ARCA:FBT) through any online brokerage.

View our list of the best stock brokerages

Who are First Trust Amex Biotech Index Fund (FBT) competitors?

There are no as such competitors for First Trust Amex Biotech Index Fund.

What is the forecast, or price target, for First Trust Amex Biotech Index Fund (FBT) stock?

There is no analysis for First Trust Amex Biotech Index Fund to provide a consensus price target.

What is the current price for First Trust Amex Biotech Index Fund (FBT)?

The stock price for First Trust Amex Biotech Index Fund (ARCA: FBT) is $ last updated .

Does First Trust Amex Biotech Index Fund (FBT) pay a dividend?

There are no upcoming dividends for First Trust Amex Biotech Index Fund.

When is First Trust Amex Biotech Index Fund (ARCA:FBT) reporting earnings?

First Trust Amex Biotech Index Fund does not have any upcoming earnings scheduled.

Is First Trust Amex Biotech Index Fund (FBT) going to split?

There is no upcoming split for First Trust Amex Biotech Index Fund.

Key Statistics

Open

High

52 Wk High

$275.23

AUM

2.92B

Dividend

$4.69

Ex-Div Date

Dec 13, 2024

Volume

Market Cap

Mgmt Fee

0.4%

P/E Ratio

Prev. Close

$265.48

Low

52 Wk Low

$186.20

Shares Out

7.55M

Yield

2.24%

Div. Freq

Avg. Volume Daily

78.36K

Beta

0.65

Avg. Expense Ratio

0.55%

P/B Ratio

About First Trust Amex Biotech Index Fund

Sector

N/A

Industry

N/A

ETF Details

Sector	Healthcare
Category	High Performer-Mid Growth
Investment Style	Mid Cap Growth
Fund Inception	Jun 19, 2006
Managers	Stan Ueland David G. McGarel Daniel J. Lindquist Roger F. Testin Erik Russo Chris A. Peterson Jon C. Erickson
Definition	This equity fund portfolio contains majority of stocks with strong financial performance and average growth potential

Investment Policy

Top ETF Holdings

Symbol	Name	Share %
CORT	Corcept Therapeutics I...	3.99%
NEO	Neogenomics Inc	3.78%
RGEN	Repligen Corp	3.90%
SM	BeOne Medicines Ltd. S...	3.71%
HALO	Halozyme Therapeutics ...	4.84%
NTRA	Natera Inc	4.62%
GMAB	Genmab A/S (Adr)	4.02%
GILD	Gilead Sciences Inc	3.73%
ILMN	Illumina, Inc.	4.51%
AMGN	Amgen Inc.	3.70%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Sector

Healthcare

Region

AUM

2.92B

Fund Score